Stock

The Chemours Company

Chemicals - Specialty · Basic Materials

Also trades as: 0HWG.L GBP 0.13 (+0.84%)

Price

$12.81

-0.22 (-1.69%)

Market Cap

$1.93B

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Oct 25, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality

Weak

2/30

Growth

Weak

2/20

Cash Flow

Weak

1/10

Stability

Weak

0/10

Valuation

Data not available

0/10

Ownership

Weak

2/15

Dividends

Mixed

2/5

9 of 100 counted points = Winston Score 9.

Track this stock — start free trial

Share count falling — buybacks

−10.8% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 168.7M (2021) → 150.6M (2025)

§Winston Score History

The full picture

Chemours is a chemical company that makes specialty materials used in many everyday products. Its biggest business is titanium dioxide, a white pigment used in paints, coatings, and plastics. It also makes Teflon-branded fluoropolymers — the slippery coating found on cookware and industrial equipment — and refrigerant gases used in air conditioners and cars. Chemours was spun off from DuPont in 2015 and inherited several of DuPont's core chemical businesses.

Chemours sells its products to manufacturers around the world, with operations across North America, Europe, and Asia. It earns revenue by selling chemicals in bulk, so profits are sensitive to commodity pricing cycles and raw material costs. The company carries significant debt and faces ongoing legal liabilities related to PFAS chemicals — a class of compounds linked to environmental contamination — which represents a major financial and regulatory risk that continues to weigh on its margins and balance sheet.

Politician Trades

1 trades / 12mo

0 Congressional buys and 1 sell on CC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-1.5% YoY

YoY Growth Rate

Revenue declining

Reported EPS Growth

+28.7% YoY

Quarterly reporting periods ended:

30 Jun 2025: $-2.54

30 Jun 2026: $-1.81

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

$108M/ year

→ Flat (-1% vs prior year)

1.9% of revenue

Below sector average (3%)

Steady R&D investment year-over-year

Insider Activity

1.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$841M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

The Chemours Company's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

18.0%

Thin — 18.0% gross margin

Profit after running costs

Operating Margin

-13.4%

Losing money on operations — -13.4%

Return on the money invested

ROCE

-5.2%

Weak — -5.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-1.4%

Shrinking sales (-1.4% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

2.2%

Thin free cash flow (2.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

20.42

Heavy debt load (20.42)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

2.65%

Moderate income — 2.65% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record

Dividend Growth

-48.1%

Dividend cut (-48.1% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial